Entries by biopoly

FDA Grants Breakthrough Device Designation to Polyganics’ Liver and Pancreas Sealant Patch

Groningen, The Netherlands, 8 March 2018 – Polyganics, a privately held medical technology company that develops, manufactures and commercializes bioresorbable medical devices, today announced that the US Food and Drug Administration (FDA) has granted Polyganics’ request for Breakthrough Device designation to its Liver and Pancreas Sealant Patch. The Liver and Pancreas Sealant patch is considered […]

Polyganics awarded €1.2 million to complete clinical development of dura sealant patch

First-in-human clinical studies of the device expected to begin in early 2018 Groningen, The Netherlands, 1 December 2017 – Polyganics, a privately held medical technology company that develops, manufactures and commercializes bioresorbable medical devices, today announced it has been awarded funding from the European Fund for Regional Development (ERDF) by the European Union, to support […]

Polyganics Extends Global Distribution Network with the Addition of Multiple US Distributors

Groningen, The Netherlands, 5 September 2017 – Polyganics, a privately held medical technology company that develops, manufactures and commercializes bioresorbable medical devices to promote peripheral nerve reconstruction and regeneration, announces the appointment of six US distributors for its peripheral nerve repair (PNR) portfolio. New agreements with Southern Orthopaedics, Medex Surgical, Rascher Medical Solutions, Med Rep […]